menu
    • menu

    Company profile for Moonlight Bio

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Moonlight Bio is a Seattle-based preclinical-stage biotechnology company advancing next-generation cell therapies to transform cancer treatment. With a multidisciplinary and collaborative team, Moonlight drives innovation across discovery research, preclinical modeling, process development, and translational studies. The company is dedicated to designing cutting-edge technologies that improve patient outcomes while fostering a...
    Moonlight Bio is a Seattle-based preclinical-stage biotechnology company advancing next-generation cell therapies to transform cancer treatment. With a multidisciplinary and collaborative team, Moonlight drives innovation across discovery research, preclinical modeling, process development, and translational studies. The company is dedicated to designing cutting-edge technologies that improve patient outcomes while fostering a culture of balance, creativity, and purpose inspired by the spirit of the Pacific Northwest.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Moonlight BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1150 Eastlake Ave E Suite 500 Seattle, WA 98109
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://moonlightbio.us/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/moonlightbio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biocytogen, Moonlight Bio Partner To Advance Cell Therapies
    Biocytogen, Moonlight Bio Partner To Advance Cell Therapies

    23 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-23/biocytogen-announces-strategic-collaboration-with-moonlight-bio-to-advance-cell-therapies-using-libr

    PHARMIWEB
    23 Mar 2026
    Share Share
    Kincell Bio Advances Moonlight Bio's T Cell Candidate to Study
    Kincell Bio Advances Moonlight Bio's T Cell Candidate to Study

    07 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-07/kincell-bio-announces-collaboration-to-advance-moonlight-bio-s-lead-cell-therapy-candidate-to-clinic

    PHARMIWEB
    07 Oct 2025
    Share Share
    Maxcyte Inks Strategic License Deal With Moonlight Bio For Tumors
    Maxcyte Inks Strategic License Deal With Moonlight Bio For Tumors

    06 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/06/3161686/0/en/MaxCyte-Announces-Strategic-Platform-License-Agreement-with-Moonlight-Bio-to-Advance-T-Cell-Therapies-for-Solid-Tumors.html

    GLOBENEWSWIRE
    06 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search